OTCMKTS:BSPM

Biostar Pharmaceuticals Stock Forecast, Price & News

$0.16
+0.01 (+5.96 %)
(As of 04/20/2021 05:19 PM ET)
Add
Compare
Today's Range
$0.11
Now: $0.16
$0.16
50-Day Range
$0.15
MA: $0.18
$0.25
52-Week Range
$0.05
Now: $0.16
$0.38
Volume1,100 shs
Average Volume4,736 shs
Market Capitalization$422,400.00
P/E RatioN/A
Dividend YieldN/A
Beta1.6
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BSPM
CUSIPN/A
CIKN/A
Phone86 29 3368 6638
Employees200
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$422,400.00
Next Earnings DateN/A
OptionableNot Optionable

Headlines

Biostar Pharmaceuticals PRICES
August 2, 2020 |  markets.businessinsider.com
Best Undervalued Stock in February
May 3, 2020 |  finance.yahoo.com
Best Cheap Stocks To Buy
May 3, 2020 |  finance.yahoo.com
Cheap Stocks To Invest In
May 3, 2020 |  finance.yahoo.com
Biostar Pharmaceuticals Inc. (BSPM) Dividend History
February 14, 2020 |  www.nasdaq.com
Biostar Pharmaceuticals Inc. (BSPM) Real-Time Quotes
February 12, 2020 |  www.nasdaq.com
Biostar Pharmaceuticals Inc. (BSPM) Pre-Market Quotes
February 12, 2020 |  www.nasdaq.com
Biostar Pharmaceuticals Inc. (BSPM) After-Hours Quotes
February 12, 2020 |  www.nasdaq.com
See More Headlines

MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1934th out of 2,018 stocks

Pharmaceutical Preparations Industry

757th out of 772 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.16
+0.01 (+5.96 %)
(As of 04/20/2021 05:19 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BSPM News and Ratings via Email

Sign-up to receive the latest news and ratings for BSPM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Biostar Pharmaceuticals (OTCMKTS:BSPM) Frequently Asked Questions

What stocks does MarketBeat like better than Biostar Pharmaceuticals?

Wall Street analysts have given Biostar Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Biostar Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Biostar Pharmaceuticals' earnings last quarter?

Biostar Pharmaceuticals, Inc. (OTCMKTS:BSPM) posted its quarterly earnings data on Wednesday, November, 15th. The company reported ($0.50) EPS for the quarter. During the same quarter in the previous year, the firm posted ($3.12) EPS.
View Biostar Pharmaceuticals' earnings history
.

How has Biostar Pharmaceuticals' stock been impacted by Coronavirus (COVID-19)?

Biostar Pharmaceuticals' stock was trading at $0.08 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BSPM stock has increased by 100.0% and is now trading at $0.16.
View which stocks have been most impacted by COVID-19
.

Who are Biostar Pharmaceuticals' key executives?

Biostar Pharmaceuticals' management team includes the following people:
  • Mr. Ronghua Wang, Chairman, CEO & Pres (Age 65, Pay $16.26k)
  • Mr. Zhenghong Wang, Chief Operating Officer (Age 41, Pay $6.14k)
  • Ms. Xiaojuan Zhai, Chief Financial Officer (Age 32)
  • Prof. Xiaohui Zheng, Chief Scientist (Age 53)
  • Ms. Shuang Gong, Director of Admin. & Sec. of Board (Age 54)

Who are some of Biostar Pharmaceuticals' key competitors?

What is Biostar Pharmaceuticals' stock symbol?

Biostar Pharmaceuticals trades on the OTCMKTS under the ticker symbol "BSPM."

How do I buy shares of Biostar Pharmaceuticals?

Shares of BSPM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Biostar Pharmaceuticals' stock price today?

One share of BSPM stock can currently be purchased for approximately $0.16.

How much money does Biostar Pharmaceuticals make?

Biostar Pharmaceuticals has a market capitalization of $422,400.00.

How many employees does Biostar Pharmaceuticals have?

Biostar Pharmaceuticals employs 200 workers across the globe.

What is Biostar Pharmaceuticals' official website?

The official website for Biostar Pharmaceuticals is biostarpharmaceuticals.com.

Where are Biostar Pharmaceuticals' headquarters?

Biostar Pharmaceuticals is headquartered at NO. 588 SHIJI XI AVENUE, XIANYANG F4, 712046.

How can I contact Biostar Pharmaceuticals?

Biostar Pharmaceuticals' mailing address is NO. 588 SHIJI XI AVENUE, XIANYANG F4, 712046. The company can be reached via phone at 86 29 3368 6638.


This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.